Abstract：Objective To study the effect of repetitive transcranial magnetic stimulation (rTMS) on the score of Baker scale for suicidal ideation (SSI) in patients with depression and its therapeutic effect. Methods From September 2018 to June 2019, 112 cases with depressive patients who admitted to Ningbo Mental Hospital were selected as research subjects. They were divided into the control group and the experimental group according to the random number table method, with 56 cases in each group. The control group was treated with Escitalopram Oxalate, while the experimental group was treated with rTMS on the basis of the control group. The total effective rate, Hamilton depression scale-17 (HAMD-17) score, SSI score, the level of myelin basic protein (MBP) and brain-derived neurotrophic factor (BDNF) of the two groups were compared. Results The total effective rate of the experimental group was higher than that of the control group (P ＜ 0.05). Before treatment, there were no significant difference in HAMD-17 and SSI scores between the two groups (P > 0.05). The HAMD-17 and SSI scores of the two groups after treatment were lower than those before treatment, and the experimental group was lower than the control group (all P < 0.05). There were no significant differences in serum MBP and BDNF levels between the two groups before treatment (P > 0.05). The serum MBP levels of the two groups after treatment were lower than those before treatment, and the experimental group was lower than the control group (P < 0.05). The levels of BDNF were higher than those before treatment, and the experimental group was higher than the control group (P < 0.05). Conclusion The effect of rTMS on depressive patients is significant, which can significantly alleviate depression, greatly reduce suicidal ideation, and effectively regulate the level of MBP and BDNF in serum.
付可登 李松华 胡媛媛. 重复经颅磁刺激对抑郁症患者SSI评分的影响及治疗效果研究[J]. 中国医药导报, 2020, 17(16): 97-100.
FU Kedeng LI Songhua HU Yuanyuan. Researth on the effect of repetitive transcranial magnetic stimulation on SSI score of depression patients and its therapeutic effect. 中国医药导报, 2020, 17(16): 97-100.
[1] 何雪梅.药物联合重复经颅磁刺激疗法对老年抑郁症患者睡眠质量、认知功能及实验室指标的影响[J].中国处方药，2019，17（7）：117-118.
[2] Kopschina Feltes P，Doorduin J，Klein HC，et al. Anti-inflammatory treatment for major depressive disorder：implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy [J]. J Psychopharmacol，2017，31（9）：1149-1165.
[3] Hofmeijer-Sevink MK，Batelaan NM，van Megen HJGM，et al. Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders [J]. Can J Psychiatry，2018，63（2）：85-93.
[4] Li G，Shen Y，Luo J，et al. Efficacy of escitalopram monotherapy in the treatment of major depressive disorder：A pooled analysis of 4 Chinese clinical trials [J]. Medicine（Baltimore），2017，96（39）：e8142.
[5] 郭新毅，余果，何晓阔.重复经颅磁刺激联合帕罗西汀治疗抑郁症的Meta分析[J].康复学报，2019，29（2）：67-74.
[6] 周平，张瑶，谭庆荣.盐酸氟西汀联合重复经颅磁刺激治疗伴焦虑症状抑郁症的随机对照研究[J].中国临床医学，2017，24（5）：715-718.
[7] Beck AT，Brown GK，Steer RA. Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients [J]. Behav Res Ther，1997，35（11）：1039-1046.
[8] 中华医学会精神病学分会.中国精神障碍分类与诊断标准第三版（精神障碍分类）[J].中华精神科杂志，2001，34（3）：184-188.
[9] 李则挚，彭代辉，黄佳，等.国产与进口文拉法辛对抑郁症患者汉密尔顿抑郁及焦虑量表因子分影响的比较[J].中国神经精神疾病杂志，2012，38（12）：760-763.
[10] Kyron MJ，Hooke GR，Page AC. Daily assessment of interpersonal factors to predict suicidal ideation and non-suicidal self-injury in psychiatric inpatients [J]. J Consult Clin Psychol，2018，86（6）：556-567.
[11] 戴立磊，邹韶红，刘若楠，等.重复经颅磁刺激对抑郁症患者自杀的影响[J].中国健康心理学杂志，2015，23（6）：7-11.
[12] 郭新宇，杨媛，田丽.草酸艾司西酞普兰联合重复经颅磁刺激对改善难治性抑郁症患者执行功能的疗效研究[J].四川精神卫生，2016，29（1）：26-30.
[13] Rappaport LM，Rappaport LM，Kendler KS. Clarifying the Role of Neuroticism in Suicidal Ideation and Suicide Attempt among Women with Major Depressive Disorder [J]. Psychol Med，2017，47（13）：2334-2344.
[14] 朱俊娟，张天宏，张玲，等.高强度高频率重复经颅磁刺激对抑郁症自杀意念的疗效[J].上海交通大学学报：医学版，2019，39（5）：534-538.
[15] IsHak WW，Steiner AJ，Klimowicz A，et al. Major Depression Comorbid with Medical Conditions：Analysis of Quality of Life，Functioning，and Depressive Symptom Severity [J]. Psychopharmacol Bull，2018，48（1）：8-25.
[16] Ionescu DF，Shelton RC，Baer L，et al. Ziprasidone Augmentation for Anxious Depression [J]. Int Clin Psychopharmacol，2016，31（6）：341-346.
[17] 陈艳丽，郑婉玲，陈旭先，等.心理分析干预对首次接受重复经颅磁刺激治疗精神分裂症患者的影响[J].中外医学研究，2019，17（33）：107-109.
[18] 符夏瑜，陈雄，张云志，等.重复经颅磁刺激联合认知行为治疗对产后抑郁的疗效及其影响因素[J].临床和实验医学杂志，2018，17（17）：1883-1886.
[19] 陈泳康，李洋，李镔.西酞普兰辅助重复经颅磁刺激对成人首发抑郁症患者HAMD评分、生活质量及不良反应的影响[J].中国医药科学，2018，8（15）：220-260.
[20] Chernov AV，Remacle AG，Hullugundi SK，et al. Amino acid sequence conservation of the algesic MBP fragment is required for its interaction with CDK5 and function in pain [J]. FEBS J，2018，285（18）：3485-3502.
[21] Korrell KV，Disser J，Parley K，et al. Differential effect on myelination through abolition of activity-dependent synaptic vesicle release or reduction of overall electrical activity of selected cortical projections in the mouse [J]. J Anat，2019，235（3）：452-467.
[22] 邓旭瑶，卓恺明.奥氮平联合草酸艾司西酞普兰对抑郁症患者的疗效及对血清指标的影响[J].湖南师范大学学报：医学版，2016，13（2）：84-87.
[23] 桂燕，邢葆平，黄婉立，等.低频重复经颅磁刺激治疗精神分裂症患者的效果及对患者血清BDNF水平的影响[J].中国现代医生，2019，57（12）：1-3，8.
2020, Vol. 17 
京公网安备 11010502046598号